Hypertrophic Cardiomyopathy is under-diagnosed, overly feared, and not common enough for most cardiology practices to stay up-to-date on best practices. The 2020 ACC/AHA HCM Guidelines serve to bring the latest approaches to patients everywhere focusing on patient engagement, the role of expert centers, and evolved care pathways. Drs. Steve Ommen and Rick Nishimura will discuss these guidelines in their typical relaxed, conversational....and practical manner.
1. Highlight the most impactful changes from the 2020 HCM Guidelines
2. Explain what shared decision making includes, and how to encourage patient participation in critical decisions
3. Describe sudden death risk assessment and decisions around ICD placement
4. Discuss aspects of HCM management that aren't addressed in the HCM Guidelines